Vaccines
28 January 2020
Clover Initiates Development of Recombinant Subunit-Trimer Vaccine for Wuhan Coronavirus (2019-nCoV)28 January 2020
GSK licenses tuberculosis vaccine candidate to the Bill & Melinda Gates Medical Research Institute for continued development27 January 2020
GeoVax and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine23 January 2020
Moderna Announces Funding Award from CEPI to Accelerate Development of Messenger RNA (mRNA) Vaccine Against Novel Coronavirus23 January 2020
CEPI to fund three programmes to develop vaccines against the novel coronavirus, nCoV-201921 January 2020
Anokion Announces FDA Clearance of IND Application for its Lead Program in Celiac Disease12 January 2020
Positive Final 2-Year Topline Data in Completed DC Vaccine Phase I/II trial in AML Patients9 January 2020
SELLAS Commences Pivotal Phase 3 REGAL Study of Galinpepimut-S (GPS) in Patients with Acute Myeloid Leukemia (AML)9 January 2020
Phase I clinical trial results published for Invectys DNA Vaccine for Cancer using PharmaJet Needle-free injector7 January 2020
Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers30 December 2019
HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-201 for the Treatment of Human Papillomavirus 16-Positive Cancers27 December 2019
Sinovac Announces Approval of Varicella Vaccine for Prevention of Varicella-Zoster Virus (Chickenpox) in Children20 December 2019
Vaccitech Oncology Limited Enters Collaboration with Cancer Research UK to Fund a Phase I/IIa Clinical Trial as First-Line NSCLC Therapy20 December 2019
First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response13 December 2019
Transgene Reports on the Combination Trial of TG4010, Chemotherapy and Nivolumab in Non-Small Cell Lung Cancer11 December 2019
GemVax announced phase II results of GV1001 for Alzheimer’s disease treatment at CTAD 201910 December 2019
Emergex Successfully Completes Preclinical Testing of its Lead ‘Set-Point’ Vaccine Candidate for Dengue Fever and Other Flaviviruses9 December 2019
Nouscom – First Patient Dosed in a Phase 1 Trial With NOUS-209, an ‘off-the-shelf’ Neoantigen Cancer Vaccine, in MSI-High Solid Tumors6 December 2019
Meissa Vaccines Receives FDA Clearance of IND Application for a Phase 1 Clinical Trial of MV-012-968 for Respiratory Syncytial Virus5 December 2019
Osivax Enters Agreement with U.S. National Institutes of Health to Test Universal Flu Vaccine Candidate4 December 2019
Advaxis Announces Submission of IND Application for ADXS-HOT Drug Candidate for Prostate Cancer26 November 2019
Prokarium announces MHRA acceptance to run Phase I trial of lead vaccine against enteric fever26 November 2019
Vaccitech Provides Update on Clinical Progress for its Two Phase 2 Universal Influenza StudiesNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports